Skip to main content

Articles

1215 result(s) for 'cancer' within Journal of Ovarian Research

Page 4 of 25

  1. Ovarian cancer has the highest mortality rate among gynecological ... tumor heterogeneity. Analyzing omentum metastasis of ovarian cancer at the single-cell level may be ... and understanding omentum metastasis a...

    Authors: Dongni Zhang, Wenping Lu, Shasha Cui, Heting Mei, Xiaoqing Wu and Zhili Zhuo
    Citation: Journal of Ovarian Research 2022 15:123
    Content type: Research Published on:

  2. Several adverse effects have been related to infertility treatments, such as cancer development. In particular, the relationship between ... infertility, reproductive strategies, and risk of gynecological cancers

    Authors: Federica Tomao, Giuseppe Lo Russo, Gian Paolo Spinelli, Valeria Stati, Alessandra Anna Prete, Natalie Prinzi, Marsela Sinjari, Patrizia Vici, Anselmo Papa, Maria Stefania Chiotti, Pierluigi Benedetti Panici and Silverio Tomao
    Citation: Journal of Ovarian Research 2014 7:51
    Content type: Review Published on:

  3. Clinical outcomes of cancer cell senescence are still elusive. Here, ... activity of spontaneously and drug-inducible senescent ovarian cancer cells. Experiments were performed on tumors and tumor-derived primary...

    Authors: Szymon Rutecki, Paulina Szulc, Martyna Pakuła, Paweł Uruski, Artur Radziemski, Eryk Naumowicz, Rafał Moszyński, Andrzej Tykarski, Justyna Mikuła-Pietrasik and Krzysztof Książek
    Citation: Journal of Ovarian Research 2022 15:87
    Content type: Research Published on:

  4. Preclinical evaluation of the anti-neoplastic activity of antisense oligonucleotide (AS) suppression of human insulin-like growth factor I receptor (IGF-IR) in human epithelial ovarian cancer (EOC).

    Authors: Jie Tang, Junjun Li, Guqing Zeng, Yanxiang Tang, Wenfang Tian, Jie He, J Philippe York and Xuefeng Xia
    Citation: Journal of Ovarian Research 2013 6:71
    Content type: Research Published on:

  5. Angiogenesis and metastasis contributes substantially to the poor outcome of patients with ovarian cancer. We aimed to explore the role and ... in regulating angiogenesis and metastasis of human ovarian cancer. N...

    Authors: Yang Liu, Yan Li, Yanzhi Wu, Yiyue Zhao, Xi Hu and Chunyi Sun
    Citation: Journal of Ovarian Research 2023 16:219
    Content type: Research Published on:

  6. Among many gynecological malignancies ovarian cancer is the most prominent and leading cause ... still unknown. In the progression of ovarian cancer different non-coding RNAs have been recognized as important reg...

    Authors: Anam Beg, Rafat Parveen, Hassan Fouad, M. E. Yahia and Azza S. Hassanein
    Citation: Journal of Ovarian Research 2022 15:72
    Content type: Review Published on:

  7. Ovarian cancer is the most lethal of all gynecologic ... this signaling cascade has been linked to many cancers. Recent genomic profiling of serous ovarian carcinoma...in vitro and in vivo...models to suggest tha...

    Authors: Jolijn W Groeneweg, Rosemary Foster, Whitfield B Growdon, René HM Verheijen and Bo R Rueda
    Citation: Journal of Ovarian Research 2014 7:95
    Content type: Review Published on:

  9. Ovarian cancer is an aggressive tumor in women with ... can be used for the chemotherapy of ovarian cancer. Here, the roles of circular_0061140 ... in PTX sensitivity and malignant progression of ovarian cancer a...

    Authors: Jun Zhu, Jun-e Luo, Yurong Chen and Qiong Wu
    Citation: Journal of Ovarian Research 2021 14:136
    Content type: Research Published on:

  10. As increased angiogenesis has been linked with the progression of ovarian cancer, a number of anti-angiogenic agents have ... the front-line treatment of advanced epithelial ovarian cancer, fallopian tube cancer ...

    Authors: Gerasimos Aravantinos and Dimitrios Pectasides
    Citation: Journal of Ovarian Research 2014 7:57
    Content type: Review Published on:

  11. We previously observed the over-expression of BMP-2 in primary cultures of epithelial ovarian cancer (EOC) cells as compared to normal...1...]. Here we investigate the effect of BMP-2 on several parameters of ova...

    Authors: Cécile Le Page, Marie-Line Puiffe, Liliane Meunier, Magdalena Zietarska, Manon de Ladurantaye, Patricia N Tonin, Diane Provencher and Anne-Marie Mes-Masson
    Citation: Journal of Ovarian Research 2009 2:4
    Content type: Research Published on:

  12. Cervical cancer is the fourth-ranked cancer in the world and is associated with ... common therapeutic approaches in the treatment of cervical cancer, but because of their side effects and ... been showed that be...

    Authors: Shahla Chaichian, Bahram Moazzami, Fatemeh Sadoughi, Hamed Haddad Kashani, Marsa Zaroudi and Zatollah Asemi
    Citation: Journal of Ovarian Research 2020 13:24
    Content type: Review Published on:

  13. Epithelial ovarian cancer is one of the leading causes of gynaecological cancer morbidity and mortality in women. Early stage ovarian cancer is usually asymptomatic, therefore, is often ... localisation and plasm...

    Authors: Ratana Lim, Martha Lappas, Clyde Riley, Niels Borregaard, Holger J Moller, Nuzhat Ahmed and Gregory E Rice
    Citation: Journal of Ovarian Research 2013 6:5
    Content type: Research Published on:

  14. Ovarian cancer (OC), a frequent malignant tumor that ... , is one of the leading causes of cancer-related death in this group of individuals. For the treatment of ovarian cancer, systemic chemotherapy with platin...

    Authors: Ahmad Saburi, Mohammad Saeed Kahrizi, Navid Naghsh, Hasti Etemadi, Ahmet İlhan, Ali Adili, Shadi Ghoreishizadeh, Rozita Tamjidifar, Morteza Akbari and Gülinnaz Ercan
    Citation: Journal of Ovarian Research 2022 15:81
    Content type: Review Published on:

  15. Ovarian cancer is the most fatal gynecologic malignancy worldwide ... resistance. Therefore, a new type of ovarian cancer treatment prediction biomarker is urgently needed to ... the remaining 30 participants wer...

    Authors: Ze Li, Yongwang Hou, Meng Zhao, Tianning Li, Yahui Liu, Jiao Chang and Li Ren
    Citation: Journal of Ovarian Research 2020 13:67
    Content type: Research Published on:

  17. G protein-coupled receptor 30 (GPR30) is a 7-transmembrane estrogen receptor that functions alongside traditional estrogen receptors to regulate the cellular responses to estrogen. Recent studies suggest that GPR...

    Authors: Satoe Fujiwara, Yoshito Terai, Hiroshi Kawaguchi, Masaaki Takai, Saha Yoo, Yoshimichi Tanaka, Tomohito Tanaka, Satoshi Tsunetoh, Hiroshi Sasaki, Masanori Kanemura, Akiko Tanabe, Yoshiki Yamashita and Masahide Ohmichi
    Citation: Journal of Ovarian Research 2012 5:35
    Content type: Research Published on:

  19. Opa interacting protein 5 (OIP5), which is a cancer/testis-specific gene, plays a cancer-promoting role in various types of human cancer. However, the role of OIP5 in the carcinogenesis and progression of ovarian...

    Authors: Xin Zhang, Wenjie Gu, Aiqin Lin, Renjie Duan, Likai Lian, Yuanyuan Huang, Tiechen Li and Qing Sun
    Citation: Journal of Ovarian Research 2023 16:185
    Content type: Research Published on:

  20. Taxol resistance in serous ovarian cancer is responsible for its poor prognosis, yet ... the mechanism of Taxol resistance in serous ovarian cancer with multiple bioinformatic methods to provide novel...

    Authors: Yuqing Shen, Hui Lin, Kelie Chen, Wanzhong Ge, Dajing Xia, Yihua Wu and Weiguo Lu
    Citation: Journal of Ovarian Research 2022 15:48
    Content type: Research Published on:

  21. Ovarian cancer is a significant public health concern with a poor prognosis for epithelial ovarian cancer. To explore the potential of immunotherapy in treating epithelial ovarian cancer, we investigated the immu...

    Authors: Hua Yang, Xiangyu Gu, Rong Fan, Qun Zhu, Sen Zhong, Xirun Wan, Qian Chen, Lan Zhu and Fengzhi Feng
    Citation: Journal of Ovarian Research 2023 16:223
    Content type: Research Published on:

  23. Ovarian cancer is the most lethal gynecologic malignancy and ... is only 35% after diagnosis. Epithelial ovarian cancer is a highly metastatic disease characterized by ... and ascites. The death incidences from o...

    Authors: Subhash C Chauhan, Deepak Kumar and Meena Jaggi
    Citation: Journal of Ovarian Research 2009 2:21
    Content type: Review Published on:

  24. C3AR1 was reported in driving tumor immunity in multiple cancers. However, its roles in ovarian cancer remain unclear. This study aims to determine ... and regulating tumor infiltrating immune cells of ovarian cancer

    Authors: Jinfa Huang, Lei Zhou and Kaixian Deng
    Citation: Journal of Ovarian Research 2023 16:64
    Content type: Research Published on:

  25. Ovarian cancer is the most lethal gynecologic malignancy worldwide. ... PARP), is becoming widely used in ovarian cancer treatment. The overall survival of ovarian cancer has not been significantly changed over t...

    Authors: Wenjing Hu, Min Li, Youguo Chen and Xinxian Gu
    Citation: Journal of Ovarian Research 2021 14:121
    Content type: Research Published on:

  26. Ovarian cancer is a common cause of death among ... been confirmed to be an oncogene involved in cancer progression, such as gastric cancer. However, the role of circ_0000144 in ovarian cancer remains unclear and...

    Authors: Dandan Wu, Jia Liu, Liji Yu, Shaofang Wu and Xiaomei Qiu
    Citation: Journal of Ovarian Research 2022 15:113
    Content type: Research Published on:

  28. The production of ascites is a common complication of ovarian cancer. Ascites constitute a unique tumor microenvironment that ... this context, we recently showed that ovarian cancer ascites may protect tumor cel...

    Authors: Denis Lane, Isabelle Matte, Claudine Rancourt and Alain Piché
    Citation: Journal of Ovarian Research 2010 3:1
    Content type: Research Published on:

  29. Ovarian cancer has the worst outcome among gynecological malignancies; ... ) and clarified the prognostic relevance in ovarian cancer.

    Authors: Ryoya Miyakawa, Makoto Kobayashi, Kotaro Sugimoto, Yuta Endo, Manabu Kojima, Yasuyuki Kobayashi, Shigenori Furukawa, Tsuyoshi Honda, Takafumi Watanabe, Shigeyuki Asano, Shu Soeda, Yuko Hashimoto, Keiya Fujimori and Hideki Chiba
    Citation: Journal of Ovarian Research 2023 16:95
    Content type: Research Published on:

  30. Evaluate and compare the utility of serum folate receptor alpha (FRA) and megakaryocyte potentiating factor (MPF) determinations relative to serum CA125, mesothelin (MSLN) and HE4 for the diagnosis of epithelial ...

    Authors: Daniel J O’Shannessy, Elizabeth B Somers, Leslie M Palmer, Robert P Thiel, Pankaj Oberoi, Ryan Heath and Lisa Marcucci
    Citation: Journal of Ovarian Research 2013 6:29
    Content type: Research Published on:

  31. Ovarian cancer is a leading cause of death among ... and increased lipid biosynthesis are key factors driving cancer cell growth. Stearoyl-CoA desaturase 1 ( ... expression and significance of SCD1 in epithelial ...

    Authors: Juwon Lee, Suin Jang, Jihye Im, Youngjin Han, Soochi Kim, HyunA Jo, Wenyu Wang, Untack Cho, Se Ik Kim, Aeran Seol, Boyun Kim and Yong Sang Song
    Citation: Journal of Ovarian Research 2024 17:73
    Content type: Research Published on:

  32. Estrogen causes proliferation of ovarian cancer cells. Although hormone therapy with an anti ... is an optional therapy for recurrent epithelial ovarian cancers, both basic and clinical researches are insufficien...

    Authors: Hachidai Hirakawa, Yoshihito Yokoyama, Hidemi Yoshida and Hideki Mizunuma
    Citation: Journal of Ovarian Research 2014 7:4
    Content type: Research Published on:

  34. There is a clinical need for routinely available genomic biomarker testing in newly diagnosed ovarian cancer. In the current study we performed molecular ... prognostic biomarkers in archival diagnostic tissue fr...

    Authors: Shelly Gunn, Xavier Reveles, Korrie Weldon, Andres Barrera, Mariam Ishaque, Dale Taylor, Chris McCaskill, Jaeweon Kim, Rashmi Shah, Mansoor Mohammed, Todd Barry, Brianne Kaiser, Amita Patnaik and Anthony Tolcher
    Citation: Journal of Ovarian Research 2013 6:2
    Content type: Research Published on:

  37. Understanding the integration of hormone signaling and how it impacts oncogenesis is critical for improved cancer treatments. Here we elucidate GNAI2 message alterations in ovarian cancer (OvCa). GNAI2 is a heter...

    Authors: John R Raymond Jr, Kathryn M Appleton, Jennifer Y Pierce and Yuri K Peterson
    Citation: Journal of Ovarian Research 2014 7:6
    Content type: Research Published on:

  38. Ovarian cancer is the eighth most commonly occurring cancer in women. Clinically, the limitation of ... tumor DNA (ctDNA) open new way toward cancer diagnosis and treatment in a personalized manner...

    Authors: Mina Sharbatoghli, Somayeh Vafaei, Hamidreza Aboulkheyr Es, Mohsen Asadi-Lari, Mehdi Totonchi and Zahra Madjd
    Citation: Journal of Ovarian Research 2020 13:124
    Content type: Review Published on:

  39. This study aimed to explore whether the dysregulation of lnc-small nucleolar RNA host gene 1 (SNHG1) and miR-216b-5p correlated with chemoresistance and indicated poor prognosis of serous epithelial ovarian cancer

    Authors: Mei Li Pei, Zong Xia Zhao and Ting Shuang
    Citation: Journal of Ovarian Research 2020 13:144
    Content type: Research Published on:

  40. Ovarian cancer is particularly insidious in nature. Its ability ... symptoms make it the seventh leading cause of cancer related deaths in women. Additionally, the ... resistance to widely accepted chemotherapy r...

    Authors: Jennifer AA Gubbels, Nick Claussen, Arvinder K Kapur, Joseph P Connor and Manish S Patankar
    Citation: Journal of Ovarian Research 2010 3:8
    Content type: Review Published on:

  42. Cisplatin is more often used to treat ovarian cancer (OvCa), which provides modest survival advantage ... therapeutic outcomes. We have shown that ovarian cancer cells express CC chemokine receptor-9 (CCR9...

    Authors: Erica L Johnson, Rajesh Singh, Crystal M Johnson-Holiday, William E Grizzle, Edward E Partridge, James W Lillard Jr and Shailesh Singh
    Citation: Journal of Ovarian Research 2010 3:15
    Content type: Research Published on:

  44. The aim of this study was to assess the clinical value of preoperative blood levels of HE4 as a predictor of overall survival in patients with ovarian cancer and to validate previous data of HE4...

    Authors: Grigorios Kalapotharakos, Christine Asciutto, Emir Henic, Bertil Casslén and Christer Borgfeldt
    Citation: Journal of Ovarian Research 2012 5:20
    Content type: Research Published on:

  46. Among reproductive cancers, ovarian cancer leads to the highest female mortality rate. ... a natural flavonoid, exerts pharmacological effects, inhibiting cancer growth with various origins. Although multiple mec...

    Authors: Yaxian Liu, Hongwen Cao, Yanhui Zhao, Lijuan Shan and Shuhai Lan
    Citation: Journal of Ovarian Research 2022 15:57
    Content type: Research Published on:

  47. Malignant tumors are the single most common cause of death and the mortality rate of ovarian cancer is the highest among gynecological disorders. The ... by complete recovery; however, the activity of cancer cell...

    Authors: Chi-Chang Chang, Chao-Ming Hung, Yun-Ru Yang, Mon-Juan Lee and Yi-Chiang Hsu
    Citation: Journal of Ovarian Research 2013 6:41
    Content type: Research Published on:

  49. The foundation of modern ovarian cancer care is cytoreductive surgery to remove all ... . For a disease as heterogenous as ovarian cancer, they could potentially outperform conventional predictive algorithms...k-...

    Authors: Alexandros Laios, Alexandros Gryparis, Diederick DeJong, Richard Hutson, Georgios Theophilou and Chris Leach
    Citation: Journal of Ovarian Research 2020 13:117
    Content type: Research Published on:

  50. A recent study reported the role of long non-coding RNA (lncRNA) RBAT1 in promoting the development of retinoblastoma and bladder cancer. However, its function in other cancers is unclear. We then studied the rol...

    Authors: Lingye Fan, Chunyan Wang, Ping Zhan and Yaofang Liu
    Citation: Journal of Ovarian Research 2023 16:147
    Content type: Research Published on:
Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

Editor News

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.

Journal of Ovarian Research

ISSN: 1757-2215

Contact us